Ls Investment Advisors, LLC United Therapeutics Corp Transaction History

Ls Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$170.47 - $211.93 $351,168 - $436,575	-2,060 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $70,350 - $79,906	-457 Reduced 18.16%	2,060 $345,000
Q2 2020 Aug 10, 2020	BUY	$92.74 - $125.82 $12,798 - $17,363	138 Added 5.8%	2,517 $305,000
Q3 2019 Oct 31, 2019	BUY	$74.85 - $85.99 $5,538 - $6,363	74 Added 3.21%	2,379 $190,000
Q2 2019 Aug 07, 2019	SELL	$76.06 - $120.81 $81,156 - $128,904	-1,067 Reduced 31.64%	2,305 $180,000
Q1 2019 Apr 25, 2019	SELL	$107.15 - $126.84 $10,072 - $11,922	-94 Reduced 2.71%	3,372 $396,000
Q4 2018 Feb 01, 2019	BUY	$101.4 - $128.73 $2,535 - $3,218	25 Added 0.73%	3,466 $377,000
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $1,138 - $1,294	-10 Reduced 0.29%	3,441 $440,000
Q2 2018 Jul 20, 2018	BUY	$101.14 - $118.31 $8,091 - $9,464	80 Added 2.37%	3,451 $390,000
Q1 2018 May 08, 2018	SELL	$107.21 - $151.94 $27,231 - $38,592	-254 Reduced 7.01%	3,371 $379,000
Q4 2017 Feb 07, 2018	SELL	$118.58 - $151.28 $90,476 - $115,426	-763 Reduced 17.39%	3,625 $536,000
Q3 2017 Oct 19, 2017	BUY	$114.6 - $136.81 $502,864 - $600,322	4,388	4,388 $514,000

671

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.